|
|
Build Your Online Product Catalogs?
| Product Name: |
Ticagrelor
|
| Supply Ability: |
2000kg |
| Related proudcts |
gmp, 274693-27-5, dml, |
| Specifications |
CP/USP/EP |
| Price Term: |
FOB/CNF |
| Port of loading: |
ANY CHINA PORT |
| Minimum Order |
1kg |
| Unit Price: |
$440 |
|
Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the worldĄŻs first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.
|
| Company: |
Hunan warrant pharmaceutial co.,LTD
|
| Contact: |
Ms. hunanwarrant hunanwarrant |
| Address: |
Liuyang biomedical park, Kangping Road, No. 6 |
| Postcode: |
430331 |
| Tel: |
+8615773119101 |
| Fax: |
0731-83280728 |
| E-mail: |
|
|
|
|
Home
